Related Experiment Video

Updated: Aug 13, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Homocysteine, hRIP3 and congenital cardiovascular malformations

Lijun Zhao1, Guangming Wang, Danyu Lu

  • 1Department of Gynecology, Peking University People's Hospital, 100044 Beijing, China.

Anatomy and Embryology
|January 24, 2006
PubMed

Insights

Elevated homocysteine (Hcys) may cause birth defects. This study links high Hcys to overexpression of human receptor-interacting serine-threonine kinase 3 (hRIP3), a potential mechanism for congenital cardiovascular malformations.

Area of Science:

  • Cardiovascular Research
  • Developmental Biology
  • Molecular Medicine

Background:

  • Elevated serum homocysteine (Hcys) is linked to congenital cardiovascular malformations and neural tube defects.
  • A novel rat gene, rHCY2, is upregulated by Hcys and induces embryonic malformations, sharing similarities with human receptor-interacting serine-threonine kinase 3 (hRIP3).

Purpose of the Study:

  • To investigate the potential link between homocysteine-induced teratogenic effects and hRIP3.
  • To determine if elevated serum Hcys increases hRIP3 expression in humans.
  • To explore hRIP3's role in congenital cardiovascular malformations.

Main Methods:

  • Analysis of human fetal hearts (normal and abnormal) and cultured human fetal cardiomyocytes.
  • Assessing hRIP3 expression in relation to congenital cardiovascular malformations and Hcys levels.
  • Investigating the effects of folic acid and anti-hRIP3 antibodies on cardiomyocytes.

Main Results:

  • Congenital cardiovascular malformations are associated with hRIP3 overexpression.
  • Evidence suggests a link between hRIP3 overexpression and homocysteine-induced congenital cardiovascular malformations.
  • Folic acid and anti-hRIP3 antibodies helped maintain cardiomyocyte structure.

Conclusions:

  • hRIP3 overexpression is implicated in congenital cardiovascular malformations.
  • Elevated homocysteine may contribute to these defects via hRIP3.
  • Folic acid and hRIP3 inhibition show potential therapeutic benefits.

More Related Videos

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life